AU6131999A - (staphylococcus aureus) genes and polypeptides - Google Patents

(staphylococcus aureus) genes and polypeptides

Info

Publication number
AU6131999A
AU6131999A AU61319/99A AU6131999A AU6131999A AU 6131999 A AU6131999 A AU 6131999A AU 61319/99 A AU61319/99 A AU 61319/99A AU 6131999 A AU6131999 A AU 6131999A AU 6131999 A AU6131999 A AU 6131999A
Authority
AU
Australia
Prior art keywords
polypeptides
genes
staphylococcus aureus
aureus
staphylococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61319/99A
Inventor
Camella C. Bailey
Gil H. Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU6131999A publication Critical patent/AU6131999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU61319/99A 1998-09-01 1999-08-31 (staphylococcus aureus) genes and polypeptides Abandoned AU6131999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9896498P 1998-09-01 1998-09-01
US60098964 1998-09-01
PCT/US1999/019726 WO2000012678A2 (en) 1998-09-01 1999-08-31 Staphylococcus aureus genes and polypeptides

Publications (1)

Publication Number Publication Date
AU6131999A true AU6131999A (en) 2000-03-21

Family

ID=22271760

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61319/99A Abandoned AU6131999A (en) 1998-09-01 1999-08-31 (staphylococcus aureus) genes and polypeptides

Country Status (5)

Country Link
EP (1) EP1109911A4 (en)
JP (1) JP2002525083A (en)
AU (1) AU6131999A (en)
CA (1) CA2341311A1 (en)
WO (1) WO2000012678A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083924A (en) * 1998-03-12 2000-07-04 Smithkline Beecham Corporation DnaB of staphylococcus aureus
US6689595B1 (en) 1999-08-04 2004-02-10 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus thymidylate kinase
WO2001011054A1 (en) 1999-08-04 2001-02-15 Pharmacia & Upjohn Company CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB)
JP2003517818A (en) * 1999-08-04 2003-06-03 ファルマシア・アンド・アップジョン・カンパニー Crystallization and structure determination of Staphylococcus aureus thymidylate kinase
AU2001233099A1 (en) 2000-01-31 2001-08-07 Pharmacia And Upjohn Company Crystallization and structure determination of staphylococcus aureus nad synthetase
WO2001077365A2 (en) 2000-04-06 2001-10-18 Pharmacia & Upjohn Company Antimicrobial methods and materials
US6864080B2 (en) 2000-06-30 2005-03-08 Pharmacia & Upjohn Company Crystallization and structure of Staphylococcus aureus peptide deformylase
AU2003280250A1 (en) * 2002-11-05 2004-06-07 Affinium Pharmaceuticals, Inc. Crystal structures of bacterial thymidylate kinases
WO2008019162A2 (en) * 2006-01-18 2008-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
KR101661946B1 (en) 2007-08-31 2016-10-05 유니버시티 오브 시카고 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
ES2563646T3 (en) 2009-04-03 2016-03-15 University Of Chicago Compositions and methods related to protein A (SpA) variants
WO2012003474A2 (en) 2010-07-02 2012-01-05 The University Of Chicago Compositions and methods related to protein a (spa) variants
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10113189A (en) * 1996-06-06 1998-05-06 Smithkline Beecham Corp New rnasep
DE69735225T2 (en) * 1996-08-28 2006-11-02 Affinium Pharmaceuticals, Inc., Toronto Fab I enoyl-ACP reductase from staphylococci
US5827689A (en) * 1996-11-13 1998-10-27 Smithkline Beecham Corporation FabD polynucleotides
US6682919B1 (en) * 1997-11-14 2004-01-27 Smithkline Beecham Corporation FabH
US6083924A (en) * 1998-03-12 2000-07-04 Smithkline Beecham Corporation DnaB of staphylococcus aureus

Also Published As

Publication number Publication date
WO2000012678A3 (en) 2000-06-15
EP1109911A4 (en) 2005-04-27
CA2341311A1 (en) 2000-03-09
WO2000012678A2 (en) 2000-03-09
JP2002525083A (en) 2002-08-13
EP1109911A2 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
AU5636498A (en) Pesticide composition
AU4710900A (en) Sample evaporative control
AU4782099A (en) Herbicides
AU1537699A (en) Extracellular matrix-binding proteins from (staphylococcus aureus)
AU4167699A (en) Antimicrobial agents
AU5972598A (en) Pesticide compositions
AU3108399A (en) (staphylococcus aureus) genes and polypeptides
EP1233974A4 (en) 37 staphylococcus aureus genes and polypeptides
AU6131999A (en) (staphylococcus aureus) genes and polypeptides
AU4776899A (en) Herbicide
AU3687297A (en) Insecticidal composition
AU7495298A (en) Watering can
AU2579797A (en) Antimicrobial agent
AU2776397A (en) Pesticide
AU7053798A (en) Synergetic fungicide composition
AU3940697A (en) Pesticides
AU4064699A (en) Insecticide
AU7527898A (en) Herbicide
AU5903398A (en) Staphylococcus aureus histidine protein kinase essential genes
AUPP617598A0 (en) Genetic sequence and uses therefor
AUPO060996A0 (en) Sexing gene
AU2174599A (en) Hair manipulation
AU5582799A (en) Staphylococcus aureus polypeptides
AU6811698A (en) Pesticides
AU8105398A (en) Fungicide mixtures

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase